Viewing Study NCT04566393


Ignite Creation Date: 2025-12-25 @ 1:09 AM
Ignite Modification Date: 2025-12-25 @ 11:20 PM
Study NCT ID: NCT04566393
Status: AVAILABLE
Last Update Posted: 2024-09-23
First Post: 2020-09-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Expanded Access to Ulixertinib (BVD-523) in Patients with Advanced MAPK Pathway-Altered Malignancies
Sponsor: xCures
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module